The Central Drugs Standard Control Organisation (CDSCO) has issued drug alerts for specific batch of Tranexamic Acid Tablets IP (Trenaxa 500), declaring it as potentially spurious following investigations into its quality. This notification was issued on July 18, 2025.
Drug Alert for the Month of May–2025 (Revised)
A drug alert for the month of May 2025 (revised) flagged a batch of Tranexamic Acid Tablets IP (Trenaxa 500), bearing batch number 18242021A, with a manufacture date of August 2024 and an expiry date of July 2027. The reason for failure was related to the “Identification and Assay of Tranexamic Acid.”
Crucially, the purported manufacturer (as per the label claim) has informed authorities that this specific batch was not manufactured by them and is believed to be a spurious drug. The alert, issued by the Drugs Inspector, Bihar notes that while the product is suspected to be spurious, this is subject to the outcome of ongoing investigations.
You may also be interested in:
CDSCO Publishes Not Of Standard Quality And Spurious Alert For May 2025
CDSCO Publishes Not Of Standard Quality And Spurious Alert For June 2025